Due to the government shutdown, the Doubletree has extended their hotel cutoff for reservations until October 26th

Draft Agenda

An agenda will be forthcoming. For planning purposes, the conference will be from 8:00 a.m. to 5:00 p.m. for both days.

November 12th

8:00 a.m. Poster Set Up (posters will stay up for the entire meeting)
8:15 a.m. – 8:30 a.m. Opening Remarks
Robert Yarchoan, M.D.
Office of HIV and AIDS Malignancy
National Cancer Institute, NIH, USA

Geraldina Dominguez, Ph.D.
Office of HIV and AIDS Malignancy
National Cancer Institute, NIH, USA

8:30 a.m. – 10:00 a.m. HPV Vaccines
Moderator: T-C Wu, M.D., Ph.D.
Johns Hopkins University, USA
8:30 a.m. – 9:00 a.m. Plenary:  L2 as a Target for Prophylactic Human Papillomavirus Vaccination
Richard Roden, Ph.D.
Johns Hopkins University, USA  
9:00 a.m. – 9:30 a.m. Plenary:HPV Vaccination in HIV-Infected Men and Women
Joel Palefsky, M.D., FRCP
University of California, San Francisco, USA
9:30 a.m. – 10:15 a.m. Oral HPV
Moderator: Isaac R. Rodriguez-Chavez, Ph.D.
National Institute of Dental and Craniofacial Research, NIH, USA
9:30 a.m. – 9:45 a.m. HIV-Induced Epithelial-Mesenchymal Transition in Oral Mucosal Epithelial Cells Facilitates  
HPV Infection
Sharof M. Tugizov, DVM, Ph.D., D. Sc.
University of California San Francisco, USA
9:45 a.m. – 10:00 a.m. HIV-Related Immunosuppression is Associated with Higher Incidence of Oral HPV, but Not
Oral HPV Clearance
Daniel C. Beachler, MHS
Johns Hopkins University, USA
10:00 a.m. – 10:15 a.m. HIV Tat increases HPV16 Infectivity Independent of Oral Keratinocyte Terminal
Differentiation
Jennifer Webster-Cyriaque, DDS, Ph.D.
University of North Carolina, Chapel Hill, USA
10:15 a.m. – 10:45 a.m. Break and Poster Session
10:45 a.m. – 12:15 p.m. Pathogens and Host Interactions
Moderator: Corey Casper, M.D., M.P.H.
Fred Hutchinson Cancer Research Center, USA
10:45 a.m. – 11:15 a.m. Plenary:Potential Role of Graft-Versus-Host Reaction in Reducing the HIV-1 Reservoir
Daniel R. Kuritzkes, M.D.
Massachusetts General Hospital
11:15 a.m. – 11:30 a.m. Variation in Viral Gene Expression Distinguishes Two Subtypes of Kaposi Sarcoma
Dirk P. Dittmer, Ph.D.
University of North Carolina, USA
11:30 a.m. – 11: 45 a. m. Characterization of HHV-8 Gene Expression in Kaposi Sarcoma Tumors and Correlation with
Clinical Presentation and Outcomes
Warren Phipps, M.D. , M.P.H.
Fred Hutchinson Cancer Research Center, USA
11:45 a.m. – 12:00 noon Prevalent High Risk HPV Infection and Vaginal Microbiota in Nigerian Women
Clement A. Adebamowo, M.D., D.SC.
Institute of Human Virology, Abuja, Nigeria
12:00 noon - 12:15 p.m. Unmasking Lymphoma Immune Reconstitution Inflammatory Syndrome among HIV-infected
Satish Gopal, M.D.
University of North Carolina at Chapel Hill, USA
12:15 p.m. – 1:45 p.m. Lunch
12:45 p.m. – 1:45 p.m. Poster Session (Day One Presenters stand by their poster)
1:45 p.m. – 2:45 p.m. Cancer Burden in Low and Middle Income Countries
Moderator: Sam Mbulaiteye, M.D.
National Cancer Institute, NIH, USA
1:45 p.m. – 2:15 p.m. Plenary: Harnessing Cancer Registry and HIV Databases in Low and Middle Income Countries
Diego Serraino, M.D.
IRCCS Centro di Riferimento Oncologico, Italy
2:15 p.m. – 2:45 p.m. Plenary: HIV and Cancer Survival in Uganda
Anna Coghill, Ph.D.
National Cancer Institute, NIH, USA
2:45 p.m. – 3:30 p.m. Break and Poster Session (Lister Hill cafeteria closes at 3 PM)
3:30 p.m. – 5:30 p.m. KSHV Biology
Moderators: Denise Whitby, Ph.D.
National Cancer Institute, NIH, USA

Dirk P. Dittmer, Ph.D.
University of North Carolina, Chapel Hill, USA

3:30 p.m. – 3:45 p.m. Kaposi Sarcoma Herpesvirus (KSHV) Vflip Induces Systemic Endothelial Proliferation and a Proinflammatory Phenotype In Vivo
Gianna Ballon, M.D.
Weill Cornell Medical College, USA
3:45 p.m. – 4:00 p.m. Human Herpesvirus 8 Infection Induces Polyfunctional B Lymphocytes Producing Cytokines and Chemokines that Drive Kaposi’s Sarcoma
Emilee R. Knowlton
University of Pittsburgh, USA
4:00 p.m. – 4:15 p.m. Kaposi Sarcoma-Associated Human Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) Undergoes Cleavage by Caspases Following Exposure of Cells to Oxidative Stress
David A. Davis, Ph.D.
National Cancer Institute, NIH, USA
4:15 p.m. – 4:30 p.m. Regulation of Kaposi Sarcoma Herpesvirus (KSHV) Encoded Viral Interleukin 6 (vIL-6) by X-Box Binding Protein 1 (XBP-1)
Duosha Hu, M.D.
National Cancer Institute, NIH, USA
4:30 p.m. – 4:45 p.m. RNA-Independent Activation of RIG-I by Deamidation
Pinghui Feng, Ph.D.
University of Southern California, USA
4:45 p.m. – 5:00 p.m. KSHV-Dependent Activation of Platelet Derived Growth Factor Receptor Signaling is an Oncogenesis Driver and a Therapeutic Target in Kaposi’s Sarcoma
Enrique A. Mesri, Ph.D.
University of Miami, USA
5:00 p.m. – 5:15 p.m. Using Proteomics to Understand Human Target Genes of KSHV MicroRNAs
Joseph M. Ziegelbauer, Ph.D.
National Cancer Institute, NIH, USA
5:15 p.m. – 5:30 p.m. KS-Detect: A Complete “Sample-In, Answer-Out” Solution to the Diagnosis of Kaposi’s Sarcoma
Ethel Cesarman, M.D., Ph.D.
Weill Cornell Medical College, USA
5:30 p.m. End of Day One

November 13

8:00 a.m. – 8: 15 a.m. Poster Viewing
8:15 a.m. – 8:20 a.m. Day 2 Welcoming Remarks
Geraldina Dominguez, Ph.D.
National Cancer Institute, NIH, USA
8:20 a.m. – 8:30 a.m. FIC’s HIV Research Training Program
Jeanne McDermott, Ph.D., M.P.H.
Fogarty International Center, NIH, USA
8:30- a.m. – 9:30 a.m. Hepatitis C Virus
Moderator: Ren Sun, Ph.D.
University of California, Los Angeles, USA
8:30 a.m. – 9:00 a.m. Plenary: Hepatitis C and Hepatocellular Carcinoma: New Model Systems and Insights into Pathogenesis
Stan Lemon, M.D.
University of North Carolina, Chapel Hill, USA
9:00 a.m. – 9:30 a.m. Plenary: Natural Courses and Management of Chronic Viral Hepatitis B or C in the HIV-Infected
Pei-Jer Chen M.D., Ph.D.
Department of Medical Research National Taiwan University, Taiwan
9:30 a.m. – 10:00 a.m. Clinical Trials and Correlative Studies
Moderator: Alexandra M. Levine, M.D.
City of Hope National Medical Center, USA
9:30 a.m. – 9:45 a.m. Results of a Phase I Study of Lenalidomide in Patients with AIDS-Associated Kaposi Sarcoma (AMC 070)
Kelly Shimabukuro, M.D.
University of California, San Diego, USA
9:45 a.m. – 10:00 a.m. Antiretrovirals for Kaposi’s Sarcoma (ARKS): A Randomized Trial of Protease Inhibitor-Based Antiretroviral Therapy for AIDS-Associated Kaposi’s Sarcoma in Sub-Saharan Africa
Jeffrey Martin, M.D., M.P.H.
University of California, San Francisco, USA
10:00 a.m. – 10:15 a.m. PK studies - Title TBA to "Studies in Primary Cultures of Human Hepatocytes and Computer Simulations Provide Guidance For Dosing of Anticancer Drugs in Patients treated with HAART Drugs"
Raman Venkataramanan, Ph.D.
University of Pittsburgh, USA
10:15 a.m. – 10:45 a.m. Break and Poster Session
10:45 a.m. – 11:30 a.m. EBV and Lymphomagenesis  
Moderator: Elliott D. Kieff, M.D., Ph.D.
Harvard Medical School, USA

Richard F. Ambinder, M.D., Ph.D.
Johns Hopkins University School of Medicine, USA
10:45 a.m. – 11:15 a.m. Plenary:  Immune Activation and Inflammation Biomarkers and Risk for AIDS-NHL
Otoniel Martinez-Maza, PhD
University of California, Los Angeles, USA
11:15 a.m. – 11:30 a.m. Differential Expression and Prognostic Utility of Immunophenotypic Markers in Diffuse Large B-cell Lymphoma from Patients with and without HIV Infection
Chun Chao, Ph.D.
 Kaiser Permanente Southern California, USA
11:30 a.m. – 11:45 a.m. Targeting Sphingosine Kinase Induces Apoptosis and Regression of Virus-Associated Lymphoma in vivo
Chris Parsons, M.D.
LSU Health Science Center, USA
11:45 a.m. – 12:00 noon The HIV-1 Matrix Protein and AIDS-Related Lymphoma
Mark K. Lafferty
Institute of Human Virology, University of Maryland School of Medicine, USA
12:00 noon – 12: 15 p.m. Characterizing Survival in the Absence of LMP1-Mediated NFkB Signaling in the Model of EBV-Driven AIDS Lymphoma
Alexander Price
Duke University, USA
12:15 p.m. – 2:00 p.m. Lunch
1:00 pm. – 2:00 p.m. Poster Session (Day Two Presenters stand by their poster)
2:00 p.m. – 2:45 p.m. Lung Cancer
Moderator: Missak Haigentz, M.D.
Albert Einstein College of Medicine, USA
2:00 p.m. – 2:30 p.m. Plenary: Lung Cancer and Inflammation
Anil Chaturvedi, Ph.D.
National Cancer Institute, NIH, USA
2:30 p.m. – 2:45 p.m. Inflammatory Biomarkers and CT-Detected Lung Nodules: Potential Implications for Lung Cancer Screening of HIV Infected Patients
Kristina Crothers, M.D.
University of Washington School of Medicine, USA
2:45 p.m. – 3:30 p.m. Break and Poster Session (Lister Hill cafeteria closes at 3 PM)
3:30 p.m. – 5: 30 p.m. Epidemiological Studies
Moderators: Michael J. Silverberg, Ph.D., M.P.H.
Kaiser Permanente, USA

Eric Engels, M.D., M.P.H.
National Cancer Institute, NIH, USA

3:30 p.m. – 3:45 p.m. Applying the Methods of Causal Inference to HIV-Associated Malignancies: Estimation of the Impact of Antiretroviral Therapy On Kaposi’s Sarcoma Incidence in East Africa Via a Nested New User Cohort Analysis
Aggrey Semeere, M.B., Ch.B, M.Med, M.A.S
Infectious Diseases Institute, Kampala, Uganda
3:45 p.m. – 4:00 p.m. Impact of Kaposi’s Sarcoma on Survival Amongst HIV‐Infected Adults in Africa in the Era of Antiretroviral Therapy
Stephen B. Asiimwe, M.D.
Mbarara Regional Referral Hospital, Mbarara, Uganda
4:00 p.m. – 4:15 p.m. Prevalence of HIV Infection Among U.S. Hodgkin Lymphoma Cases
Meredith S. Shiels, Ph.D.
National Cancer Institute, NIH, USA
4:15 p.m. – 4:30 p.m. Risk of Non-Hodgkin Lymphoma Subtypes in People Infected with HIV During the HAART Era
Todd M. Gibson, Ph.D.
National Cancer Institute, NIH, USA
4:30 p.m. – 4:45 p.m. Time Trends of Cancer Mortality Rates Among Men in the Veterans Aging Cohort Study in the Center for AIDS Research Network of Integrated Clinical Systems
Robert Dubrow, M.D., Ph.D.
Yale School of Public Health, USA
4:45 p.m. – 5:00 p.m. Epidemiologic Contributions to Recent Cancer Trends Among HIV-Infected People in the United States
Hilary A. Robbins
National Cancer Institute, NIH, USA
5:00 p.m. – 5:15 p.m. Cancer Treatment Disparities in HIV-Infected Individuals in the United States
Gita Suneja, M.D.
University of Pennsylvania, USA
5:15 p.m. Meeting Adjourned